hotspot -WSS

hotspot

author：Wikipedia 2025-09-28 20:33:02 - browse：15

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Medical leaders decry Supreme Court decision on affirmative action

WSS

Jerome Adams on the need for new antivirals for Covid

After affirmative action ruling, medical educators look to 'holistic review'

Anesthesiologist group: stop taking Ozempic before surgery

Moonlake's readout produced a cash windfall. Risks remain

George Santos makes 1st court appearance after pleading not guilty to 13 counts

New air purifier tech could be key to improving indoor air quality

Wikipedia

hotspot

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Listen: More tumult at BIO & coercive care for sickle cell patients

Drug repurposing or repositioning? The language matters

At least 13 dead in Texas as scorching temps continue

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How to save PrEP access — and even expand it

What does generative AI mean for health care? We asked experts

The cancer drug shortage isn’t new — and neither are the solutions

focus

Fentanyl is making it harder to start addiction treatment

Trump demands the U.S. pay no more for drugs than other countries … again

The high cost of giving birth even with insurance

Peter Hotez and the public health issue of online harassment

The cancer drug shortage isn’t new — and neither are the solutions

ASCO eve: Let’s set the table for this year's meeting

leisure time

hotspot

entertainment

entertainment